Corium International, Inc.
(NASDAQ : CORI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.21%203.241.2%$406.96m
GILDGilead Sciences, Inc.
0.71%73.300.9%$397.29m
CELGCelgene Corporation
0.96%88.041.2%$342.40m
BIIBBiogen Inc.
0.61%336.431.2%$275.63m
ILMNIllumina, Inc.
1.98%354.113.5%$257.25m
REGNRegeneron Pharmaceuticals, Inc.
0.52%388.502.6%$211.34m
EXASExact Sciences Corporation
-0.86%72.7025.3%$196.98m
VRTXVertex Pharmaceuticals Incorporated
1.25%178.001.9%$161.87m
SRPTSarepta Therapeutics, Inc.
0.81%153.5916.4%$125.88m
AAgilent Technologies, Inc.
-0.57%68.691.5%$120.81m
ALXNAlexion Pharmaceuticals, Inc.
2.17%120.362.0%$109.82m
NKTRNektar Therapeutics
1.82%59.375.6%$97.71m
ALNYAlnylam Pharmaceuticals, Inc
1.03%94.319.7%$96.80m
BMRNBioMarin Pharmaceutical Inc.
1.64%99.764.4%$92.17m
INCYIncyte Corporation
1.10%67.762.5%$88.68m

Company Profile

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.